Company Profiles

driven by the PitchBook Platform

Complexa

Description

Developer of therapies for the treatment of inflammatory and metabolic diseases. The company's clinical stage platform focuses on the reserach and development of selective and reversible endogenous human cell signaling technologies targeting orphan diseases.

2008

Founded

PRIVATE

Status

Series C

Latest Deal Type

$62M

Latest Deal Amount

$84.5M

Total Amount Raised

11

Investors

Description

Developer of therapies for the treatment of inflammatory and metabolic diseases. The company's clinical stage platform focuses on the reserach and development of selective and reversible endogenous human cell signaling technologies targeting orphan diseases.

Website:

www.complexarx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

170 North Radnor Chester Road Suite 350 Radnor, PA 19087United States +1 (412) 727-8727
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Complexa's full profile, request a free trial.

    Complexa Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Complexa Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Complexa Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BlueTree Allied AngelsVenture CapitalMinority000 0000000 0000
    Edmond de Rothschild Investment PartnersPE/BuyoutMinority000 0000000 0000
    HBM Healthcare InvestmentsVenture CapitalMinority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    Innovation WorksVenture CapitalMinority000 0000000 0000
    BlueTree Allied Angels Venture Capital
    Edmond de Rothschild Investment Partners PE/Buyout
    HBM Healthcare Investments Venture Capital
    Individual Investor Angel (individual)
    Innovation Works Venture Capital

    Complexa Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Joshua TarnoffChief Executive Officer, President & Board Member
    Arthur FinnelChief Financial Officer
    Federica O'BrienChief Financial Officer
    Bruce FreemanCo-Founder
    Meg Tarpey MDCo-Founder
    Joshua Tarnoff Chief Executive Officer, President & Board Member
    Arthur Finnel Chief Financial Officer
    Federica O'Brien Chief Financial Officer
    Bruce Freeman Co-Founder
    Meg Tarpey MD Co-Founder

    Complexa Board Members (13)

    NameRepresentingRoleSinceContact
    Info
    Barbara Dalton Ph.DPfizer Venture InvestmentsVice President000 0000
    Carter Meyer JDSelfBoard Member000 0000
    David MottNew Enterprise AssociatesGeneral Partner000 0000
    Gilles NobécourtEdmond de Rothschild Investment PartnersPartner000 0000
    Harold Safferstein Ph.DPittsburgh Life Sciences GreenhouseExecutive-in-Residence000 0000
    Barbara Dalton Ph.D Vice President Pfizer Venture Investments
    Carter Meyer JD Board Member Self
    David Mott General Partner New Enterprise Associates
    Gilles Nobécourt Partner Edmond de Rothschild Investment Partners
    Harold Safferstein Ph.D Executive-in-Residence Pittsburgh Life Sciences Greenhouse
    Request full access to PitchBook